Related Experiment Video
Updated: Dec 8, 2025

Trajectory Data Analyses for Pedestrian Space-time Activity Study
Published on: February 25, 2013
Patient Trajectories Among Persons Hospitalized for COVID-19 : A Cohort Study
Brian T Garibaldi1, Jacob Fiksel2, John Muschelli2
1Johns Hopkins University School of Medicine, Baltimore, Maryland (B.T.G., M.L.R., P.N., J.H.G., H.M., T.M.N., B.S.K., P.M.H., R.B., D.R.T., M.G.B., A.R., A.G.).
Predicting severe coronavirus disease 2019 (COVID-19) progression is crucial. Demographic and clinical factors at admission can identify high-risk patients early, aiding clinical decisions and resource allocation.
Area of Science:
- Infectious Diseases
- Public Health
- Clinical Medicine
Background:
- Risk factors for severe coronavirus disease 2019 (COVID-19) progression in U.S. patient cohorts remain underexplored.
- Identifying predictors of severe COVID-19 or death is essential for timely intervention.
Purpose of the Study:
- To identify factors present at hospital admission that predict severe COVID-19 disease or death.
- To develop a predictive model for in-hospital disease progression.
Main Methods:
- Retrospective cohort analysis of 832 COVID-19 admissions across five hospitals.
- Patient outcomes were categorized using the World Health Organization COVID-19 disease severity scale.
- Analysis included demographic and clinical variables, laboratory results, and vital signs.
Main Results:
- A significant proportion of patients admitted with mild to moderate COVID-19 progressed to severe disease or death within days.
- Factors including age, nursing home residence, comorbidities, obesity, respiratory symptoms, vital signs, and specific laboratory values (lymphocyte count, albumin, troponin, CRP) were associated with progression.
- A predictive model using admission data demonstrated strong performance (AUC 0.79-0.85) for forecasting in-hospital disease progression.
Conclusions:
- A combination of demographic and clinical factors at admission strongly predicts severe COVID-19 outcomes and early onset.
- The COVID-19 Inpatient Risk Calculator (CIRC) can inform clinical management and resource allocation decisions for hospitalized patients.
Related Concept Videos
Bioavailability Study Design: Healthy Subjects Versus Patients
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia III: Complications and Assessment
Hospitals-II
Nurses that work in...
Methods of Documentation VI: Case Management Model
For example, a patient with a chronic...

